Jane Street Group LLC Purchases 341,790 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Jane Street Group LLC boosted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 1,080.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 373,423 shares of the medical instruments supplier's stock after purchasing an additional 341,790 shares during the quarter. Jane Street Group LLC owned about 0.19% of DENTSPLY SIRONA worth $7,088,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Comerica Bank increased its stake in shares of DENTSPLY SIRONA by 41.2% in the 4th quarter. Comerica Bank now owns 225,080 shares of the medical instruments supplier's stock valued at $4,272,000 after acquiring an additional 65,709 shares during the last quarter. AQR Capital Management LLC boosted its position in shares of DENTSPLY SIRONA by 245.1% during the fourth quarter. AQR Capital Management LLC now owns 2,893,023 shares of the medical instruments supplier's stock worth $54,389,000 after purchasing an additional 2,054,767 shares in the last quarter. Northern Trust Corp grew its holdings in shares of DENTSPLY SIRONA by 14.9% in the 4th quarter. Northern Trust Corp now owns 2,082,391 shares of the medical instruments supplier's stock valued at $39,524,000 after buying an additional 269,502 shares during the period. Tudor Investment Corp ET AL bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter valued at $1,426,000. Finally, Quarry LP raised its stake in DENTSPLY SIRONA by 25.7% during the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after buying an additional 780 shares during the period. Institutional investors and hedge funds own 95.70% of the company's stock.

Insiders Place Their Bets

In related news, Director Gregory T. Lucier acquired 15,142 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares of the company's stock, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.50% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on XRAY shares. UBS Group lowered their price target on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a report on Friday. Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a report on Friday, February 28th. Morgan Stanley cut shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price target for the company. in a report on Tuesday, April 15th. StockNews.com upgraded shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Friday. Finally, Mizuho reduced their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research note on Thursday, March 13th. Eleven analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $20.27.

DENTSPLY SIRONA Stock Down 0.6 %

XRAY stock traded down $0.10 during mid-day trading on Friday, reaching $15.81. The company had a trading volume of 4,397,789 shares, compared to its average volume of 2,959,440. The company has a market capitalization of $3.15 billion, a price-to-earnings ratio of -7.64, a PEG ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a 52 week low of $12.16 and a 52 week high of $28.69. The stock has a 50 day simple moving average of $14.36 and a two-hundred day simple moving average of $17.54. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.14. The business had revenue of $879.00 million during the quarter, compared to analysts' expectations of $854.75 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm's revenue was down 7.8% on a year-over-year basis. During the same period last year, the business earned $0.42 earnings per share. As a group, equities analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.05%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA's payout ratio is currently -14.10%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.